318 related articles for article (PubMed ID: 18804190)
21. Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation.
Su Z; Yuan Y; Cao L; Zhu Y; Gao L; Qiu Y; He C
Glia; 2010 Jun; 58(8):901-15. PubMed ID: 20155820
[TBL] [Abstract][Full Text] [Related]
22. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis.
Zhang W; Lu C; Liu Z; Yang D; Chen S; Cha A; Wu Z; Lu A
Planta Med; 2007 Apr; 73(4):336-40. PubMed ID: 17354165
[TBL] [Abstract][Full Text] [Related]
25. Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription.
Chen Y; Zhang J; Li J; Zhao T; Zou L; Tang Y; Zhang X; Wu Y
Mol Immunol; 2006 Mar; 43(8):1088-98. PubMed ID: 16129490
[TBL] [Abstract][Full Text] [Related]
26. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.
Sasaoka T; Ito M; Yamashita J; Nakajima K; Tanaka I; Narita M; Hara Y; Hada K; Takahashi M; Ohno Y; Matsuo T; Kaneshiro Y; Tanaka H; Kaneko K
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G568-76. PubMed ID: 21193526
[TBL] [Abstract][Full Text] [Related]
27. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens JL
Eur J Immunol; 2001 May; 31(5):1550-60. PubMed ID: 11465113
[TBL] [Abstract][Full Text] [Related]
28. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
29. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages.
Andou A; Hisamatsu T; Okamoto S; Chinen H; Kamada N; Kobayashi T; Hashimoto M; Okutsu T; Shimbo K; Takeda T; Matsumoto H; Sato A; Ohtsu H; Suzuki M; Hibi T
Gastroenterology; 2009 Feb; 136(2):564-74.e2. PubMed ID: 19027739
[TBL] [Abstract][Full Text] [Related]
30. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis.
Ghia JE; Blennerhassett P; El-Sharkawy RT; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G711-8. PubMed ID: 17673544
[TBL] [Abstract][Full Text] [Related]
31. Exploring a novel triptolide derivative possess anti-colitis effect via regulating T cell differentiation.
Fu J; Zang Y; Zhou Y; Chen C; Shao S; Shi G; Wu L; Zhu G; Sun T; Zhang D; Zhang T
Int Immunopharmacol; 2021 May; 94():107472. PubMed ID: 33611058
[TBL] [Abstract][Full Text] [Related]
32. Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn's colitis.
Li Y; Tian Y; Zhu W; Gong J; Zhang W; Yu C; Gu L; Li N; Li J
Int Immunopharmacol; 2013 Jun; 16(2):268-74. PubMed ID: 23643741
[TBL] [Abstract][Full Text] [Related]
33. Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1 cells.
Liu J; Wu QL; Feng YH; Wang YF; Li XY; Zuo JP
Acta Pharmacol Sin; 2005 Feb; 26(2):223-7. PubMed ID: 15663903
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a novel IL-10 deficient cell transfer model for colitis.
Ikenoue Y; Tagami T; Murata M
Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.
Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B
J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618
[TBL] [Abstract][Full Text] [Related]
36. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
37. IL-10 gene therapy prevents TNBS-induced colitis.
Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
Gene Ther; 2002 Dec; 9(24):1715-21. PubMed ID: 12457286
[TBL] [Abstract][Full Text] [Related]
38. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
39. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
